Reply

Affiliations

¹ Division of Gastroenterology, Department of Medicine, Division of Biomedical Informatics, Department of Medicine, University of California San Diego, La Jolla, California.

Comment

Siddharth Singh. Clin Gastroenterol Hepatol. 2021 Oct.

. 2021 Oct;19(10):2221.

doi: 10.1016/j.cgh.2020.11.036. Epub 2020 Dec 3.

¹ Division of Gastroenterology, Department of Medicine, Division of Biomedical Informatics, Department of Medicine, University of California San Diego, La Jolla, California.

No abstract available

Comment on

First- and Second-Line Pharmacotherapies for Patients With Moderate to Severely Active Ulcerative Colitis: An Updated Network Meta-Analysis.
Singh S, Murad MH, Fumery M, Dulai PS, Sandborn WJ. Singh S, et al. Clin Gastroenterol Hepatol. 2020 Sep;18(10):2179-2191.e6. doi: 10.1016/j.cgh.2020.01.008. Epub 2020 Jan 13. Clin Gastroenterol Hepatol. 2020. PMID: 31945470 Free PMC article.
Network Meta-analysis of Ulcerative Colitis Pharmacotherapies: Carryover Effects From Induction and Bias of the Results.
Naessens D, Cameron C, Hoaglin DC. Naessens D, et al. Clin Gastroenterol Hepatol. 2021 Oct;19(10):2219-2221. doi: 10.1016/j.cgh.2020.10.016. Epub 2020 Oct 13. Clin Gastroenterol Hepatol. 2021. PMID: 33065309 No abstract available.